bims-miptne Biomed News
on Mitochondrial permeability transition pore-dependent necrosis
Issue of 2026–11–15
seven papers selected by
Oluwatobi Samuel Adegbite, University of Liverpool



  1. Science. 2026 Nov 12. 394(6825): eaeh3996
      Lysosomal Ca2+ release from acidic stores is critical for lysosomal function, yet the molecular identity of the Ca2+ uptake conduit has remained elusive. We used a Ca2+-imaging-based genetic screen of the lysosomal membrane proteome to identify TMEM184 family proteins as lysosomal Ca2+ transporters (LyCaTs) essential for Ca2+ uptake and refilling. TMEM184 selectively transported Ca2+ while excluding monovalent cations. Loss of TMEM184B/C depleted lysosomal Ca2+ stores, diminished Ca2+ release, and disrupted lysosomal exocytosis, biogenesis, and membrane repair, thus phenocopying the release channel transient receptor potential mucolipin 1 (TRPML1) deficiency. Moreover, a human TMEM184B mutation associated with a neurodevelopmental disorder compromised lysosomal Ca2+ transport, and Tmem184b-deficient mice exhibited profound motor impairment. Thus, TMEM184 constitutes the long-sought Ca2+ uptake and refilling mechanism that governs lysosomal signaling and homeostasis.
    DOI:  https://doi.org/10.1126/science.aeh3996
  2. Proc Natl Acad Sci U S A. 2026 Nov 17. 123(46): e2613433123
      The electron transport chain is a signaling hub for hydrogen sulfide (H2S) that serves both as a respiratory substrate and an inhibitor. While acute sulfide toxicity is well characterized, cellular adaptations to chronic H2S, particularly microbially-derived sulfide exposure in colon, is poorly understood. We report that chronic, low-level H2S exposure (4 to 20 µM) drives robust carbon sequestration in lipid droplets (LD) across several human cell lines, driven by a coordinated remodeling of redox and nucleotide metabolism. Specifically, H2S-induced reductive shifts in nicotinamide adenine dinucleotide (NAD) and coenzyme Q (CoQ) pools are accompanied by glycerol-3-phosphate accumulation and cytidine triphosphate (CTP) depletion. Lipidomic analysis reveals increased neutral lipid synthesis and triacylglyceride accumulation concomitant with decreased CTP-dependent synthesis of membrane phospholipids. Mitochondrial expression of a water-generating NADH oxidase attenuates LD accumulation and spatially confines the origin of H2S-induced reductive stress signaling to this compartment. Interestingly, LD abundance increases even after H2S withdrawal, continuing over 48 h, during which time the reductively-shifted NAD and CoQ pools slowly reoxidize. Inhibition of fatty acid synthesis during sulfide exposure impairs cellular recovery of respiration. These findings establish an active role for LDs in stress response and reveal that lipid biogenesis is a strategy for countering H2S-induced redox imbalance. The sulfide-LD-redox axis uncovered in this study has implications for understanding how gut-derived H2S, shaped by diet and microbiome, can influence metabolic health.
    Keywords:  lipid droplet; metabolism; redox
    DOI:  https://doi.org/10.1073/pnas.2613433123
  3. Cancer Immunol Res. 2026 Nov 12.
      Natural killer (NK) cells offer a promising off-the-shelf platform for cancer immunotherapy, yet their clinical efficacy is often limited by tumor-intrinsic resistance. Here, we show that loss of core microRNA (miRNA) machinery components, Argonaute‑2 (AGO2) or Ankyrin Repeat Domain 52 (ANKRD52), renders tumor cells hypersensitive to NK cell-mediated killing in both co-culture and xenograft models. Mechanistically, genetic ablation of Ago2 or Ankrd52 impairs miRNA-mediated silencing of critical mitochondrial apoptotic regulators and NK-cell-associated ligands in tumor cells, exemplified by the disrupted repression of pro-apoptotic Bim transcripts by miR-24 and miR-29b, thereby unleashing rapid TNF-α-driven apoptosis. Additionally, metabolic and ultrastructural analyses demonstrate collapsed membrane potential, diminished ATP levels, and fragmented mitochondria in Ago2- or Ankrd52-mutant tumor cells, accompanied by a lower apoptotic threshold upon TNF-α or NK cell challenge. Genome‑wide CRISPR library screen further revealed a selective fitness dependency on mitochondrial electron‑transport and ATP‑synthase genes in mutant tumor cells. Collectively, these findings define defective miRNA machinery as a tumor‑intrinsic vulnerability that couples mitochondrial fragility with increased NK-mediated cytotoxicity, nominate miRNA‑pathway status as a predictive biomarker, and propose that co‑targeting mitochondrial metabolism or apoptosis may potentiate NK‑cell therapies.
    DOI:  https://doi.org/10.1158/2326-6066.CIR-26-0559
  4. Nature. 2026 Nov 11.
      Transcriptional addiction to the androgen receptor (AR) underlies metastatic castration-resistant prostate cancer1, in which AR maintains oncogenic programs through domain-specific interactions with the acetyltransferases p300 and CBP (collectively p300/CBP)2. Here we describe a novel therapeutic modality, domain-alteration chimeras (DALTACs), that rewire endogenous protein complexes by enforcing non-native domain-domain interactions. Our first-in-class AR-p300/CBP DALTAC-1 induces synthetic proximity between the ligand-binding domain of AR and the bromodomain of p300/CBP, misconfiguring their native interface and locking the complex in a non-productive state. DALTAC-1 triggers a 'super-inhibitory' effect, suppressing AR-driven transcription and proliferation more potently than combined AR and p300/CBP inhibition. Mechanistically, DALTAC-1 reprograms p300/CBP substrate engagement, abolishing the histone mark H2B N-terminal acetylation and inducing neomorphic acetylation of AR and coactivators, ultimately collapsing the AR neo-enhanceosome. Chromatin profiling revealed redistribution of AR and p300/CBP towards palindromic androgen response elements, accompanied by disruption of cofactor and transcriptional machinery recruitment at oncogenic AR and ERG neo-enhancers. DALTAC-1 exhibits exquisite lineage selectivity, displaying potent activity in AR-p300/CBP dual-dependent cells and sparing AR-negative cells. In multiple in vivo models, DALTAC-1 induces deep and durable tumour regressions. Together, these findings establish DALTACs as a broadly applicable strategy to rewire disease-defining complexes through domain-topology alteration, expanding induced-proximity therapies, and the precise lineage selectivity of DALTAC-1 supports its translational potential in AR-driven prostate cancer.
    DOI:  https://doi.org/10.1038/s41586-026-11262-4
  5. Nature. 2026 Nov 11.
      Disconnects between in vitro and in vivo results in experimental biology have long been recognized as potential hurdles to understanding health and disease. A prototypical example of such a disconnect is the NLRP3 inflammasome, which mediates inflammation in diverse settings of disease and protective immunity1,2. Activation of the NLRP3 inflammasome in vitro requires two signals: (1) priming by pathogen-associated molecular patterns such as bacterial lipopolysaccharides and (2) activation by molecules that disrupt cellular homeostasis1,3. By contrast, the NLRP3 inflammasome in vivo is activated by lipopolysaccharide alone. The mechanisms that underlie the difference between in vitro and in vivo activation of the NLRP3 inflammasome are undefined. Here we report that extracellular matrix (ECM) stiffness is a determinant of NLRP3 activities and that in vitro systems using physiological ECM stiffness enable one-signal in vivo-like NLRP3 activities to occur in human and mouse phagocytes. Physiological ECM stiffness induced expression of the transcription factor NRF2, which was found to be necessary for one-signal NLRP3 activation. Mechanistically, we identify Panx1 as an NRF2-regulated gene that promotes NLRP3 activity. Macrophages derived from the stiff matrix of the bone-osteoclasts-had reduced NRF2 levels and impaired NLRP3 activity. Moreover, alveolar macrophages from patients with pulmonary fibrosis displayed reduced NRF2 activity. Finally, NRF2 was required for antitumour immunity induced by cancer vaccines consisting of NLRP3 agonistic adjuvants. These findings indicate that NRF2 may be a transcriptional checkpoint that controls NLRP3 inflammasome activity.
    DOI:  https://doi.org/10.1038/s41586-026-11324-7
  6. Nature. 2026 Nov 11.
      The nuclear pore complex (NPC) regulates molecular traffic between nucleus and cytoplasm1,2. Its permeability barrier is formed by intrinsically disordered phenylalanine-glycine-rich nucleoporins (FG-NUPs), whose physical state has long been debated3-13. Deciphering how FG-NUPs behave inside living cells is crucial for understanding how NPCs achieve both selective and rapid transport. By combining site-specific labelling with time-resolved fluorescence anisotropy, here we show that FG domains exhibit nanosecond-scale, liquid-like segmental motion in live cells, whereas reconstituted FG condensates undergo a liquid-to-solid transition in vitro. Experiments and molecular-dynamics simulations further show that importin-β, a principal nuclear transport receptor, and O-linked β-N-acetylglucosamine, a key post-translational modification of FG-NUPs, together stabilize the dynamic FG network. Finely balanced FG-FG and FG-importin-β interactions maintain FG-NUP liquidity and generate a radial organization in which importin-β is enriched near the NPC periphery and extended FG domains remain in the central channel, forming the transport barrier. This organization explains recent MINFLUX observations14 of rim-biased transport trajectories and is supported here by direct MINFLUX imaging of importin-β in mammalian cells. Together, our results reconcile conflicting models of FG-NUP organization4,5,7,9,15 and establish a framework for understanding how cellular context tunes intrinsically disordered proteins in health and disease.
    DOI:  https://doi.org/10.1038/s41586-026-11258-0
  7. Proc Natl Acad Sci U S A. 2026 Nov 17. 123(46): e2537870123
      Chronic kidney disease (CKD) represents a major medical burden. Diabetic kidney disease (DKD) is a leading cause of CKD, but intracellular pathways that can be pharmacologically targeted are poorly defined. Using transcriptome screening of DKD model mice we found that a carbohydrate-responsive element-binding protein (ChREBP)-dependent transcriptional cascade is markedly up-regulated in diabetic kidneys. Genetic ablation of ChREBP in diabetic mice ameliorated DKD, establishing ChREBP as a potential causal driver. A chemical screen based on ChREBP transcriptional activity identified D-532 as a small-molecule inhibitor that is effective in human and rodent cells. Oral administration of D-532 protected multiple diabetic mouse models from DKD progression and suppressed ChREBP and its downstream targets, including genes associated with excessive reactive oxygen species production. These findings position ChREBP as a pharmacologically targetable transcriptional driver of DKD and provide proof of concept that ChREBP inhibition can confer renal protection.
    Keywords:  diabetes mellitus; diabetic kidney disease; glomerulus; kidney; proximal tubular cells
    DOI:  https://doi.org/10.1073/pnas.2537870123